Race and outcomes of autologous hematopoietic cell transplantation for multiple myeloma. - Wikidata - wikimedia - TriplyDB

Race and outcomes of autologous hematopoietic cell transplantation for multiple myeloma.

Race and outcomes of autologous hematopoietic cell transplantation for multiple myeloma.

http://www.wikidata.org/entity/Q33708469

about

Human leukocyte antigen profiles of latin american populations: differential admixture and its potential impact on hematopoietic stem cell transplantation Trends in utilization and outcomes of autologous transplantation as early therapy for multiple myeloma.Salvage second hematopoietic cell transplantation in myeloma Racial disparities in incidence and outcome in multiple myeloma: a population-based study.Disparities in utilization of autologous hematopoietic cell transplantation for treatment of multiple myeloma Racial disparities in hematopoietic cell transplantation in the United States.Persistent Disparities in Adult Hematopoietic Cell Transplantation.Hispanics have the lowest stem cell transplant utilization rate for autologous hematopoietic cell transplantation for multiple myeloma in the United States: A CIBMTR report.Disparities in black and white patients with multiple myeloma referred for autologous hematopoietic transplantation: a single center study.Equal Treatment and Outcomes for Everyone with Multiple Myeloma: Are We There Yet?Post-Transplant Outcomes in High-Risk Compared with Non-High-Risk Multiple Myeloma: A CIBMTR Analysis.Population-Based Analysis of Hematologic Malignancy Referrals to a Comprehensive Cancer Center, Referrals for Blood and Marrow Transplantation, and Participation in Clinical Trial, Survey, and Biospecimen Research by Race.Variation in incidence and survival by ethnicity for patients with myeloma in England (2002-2008).Salvage autologous stem cell transplantation for multiple myeloma relapsing or progressing after up-front autologous transplantation.Recent improvement in survival of patients with multiple myeloma: variation by ethnicity.Hematopoietic progenitor cell transplantation toxicities in multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw: a longitudinal cohort study.Association of socioeconomic status with autologous hematopoietic cell transplantation outcomes for lymphoma.

P2860

Q28280748-9BCAC7FC-0FAE-4D18-BCDD-35EA2C42FC77 Q30409713-C54AC2F7-B2F1-4EB6-9C1D-57189312E04E Q30416452-1BE69E0E-11CA-4E20-81F0-55C7C49291DB Q34541680-D47200C1-4E05-4172-8416-F3DC78CD8C86 Q35180533-DD8363A8-FE87-412E-A226-7231BAF7FDBB Q37358914-238B1A06-9E32-4327-B45B-80625A2A1E39 Q38536214-A8AE64AF-F368-492D-A32C-A4105E554488 Q38803906-4FDD77AA-773D-45EB-946C-2D55037D1284 Q39084779-E241E70F-2CC8-4C44-8E86-D41DFD60110E Q39381877-A01D906D-B40A-4968-AE23-96828CA7D20E Q39518931-62435490-B580-4AAD-8F33-B2555CCF730C Q41032965-56ED80C7-FF10-4015-AFCD-8648AA11ECCE Q41479797-CC26CBD3-1757-45CA-A7D2-CED373155C11 Q44385832-4E069A24-35EC-4BB0-BFCC-E4EE6C468C2D Q46717038-ED6E2C1B-F3CE-4A54-B34C-212D6AFADDD7 Q48713974-A5C2F1B1-6805-4BB7-9D3A-6B88E4FA0CCB Q50216037-A43688C3-7BCA-4FC4-8D7F-941773EC887C

P2860

Race and outcomes of autologous hematopoietic cell transplantation for multiple myeloma.

http://www.wikidata.org/entity/Q33708469

description

2009 nî lūn-bûn

@nan

2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Race and outcomes of autologous hematopoietic cell transplantation for multiple myeloma.

@ast

Race and outcomes of autologous hematopoietic cell transplantation for multiple myeloma.

@en

type

label

Race and outcomes of autologous hematopoietic cell transplantation for multiple myeloma.

@ast

Race and outcomes of autologous hematopoietic cell transplantation for multiple myeloma.

@en

prefLabel

Race and outcomes of autologous hematopoietic cell transplantation for multiple myeloma.

@ast

Race and outcomes of autologous hematopoietic cell transplantation for multiple myeloma.

@en

P1433

Q33708469-E557957E-DA6B-4AA2-BB4A-D6E75C4A34F2

P1476

Q33708469-02C3CB02-0369-40FE-8CAD-9F799C49A6A0

P2093

Q33708469-0B9CB6EE-C096-47DF-A2EC-93703E5DBE25

Q33708469-0FBEAA31-5719-4666-8B41-158AB23EF5E4

Q33708469-3E036240-E9EC-41EB-8604-CCCEA65DF363

Q33708469-43BDEA02-8288-48BB-838C-8A37408A43E4

Q33708469-4A7E3732-CC93-4494-9C3B-8F4B28FD7F6A

Q33708469-4F9BEEB5-6692-4C2B-ACDA-43A6D8707A72

Q33708469-5252A4F2-1CC5-41D9-B393-F5B7DF0777FB

Q33708469-82C26109-30E4-4EFC-AB4A-CDE8359ABB62

Q33708469-8D25115D-0EA7-4F09-B3D0-EF6BE0C45F31

Q33708469-90CF7998-65D4-49BB-979B-93139453C3D6

P2860

Q33708469-04671073-16C3-4115-B6FA-FCEEE7823337

Q33708469-06F46A51-C2D8-4620-8FBC-B0DEDF926A02

Q33708469-0B0A00FA-157E-454E-BD17-96BD041AEA13

Q33708469-31BCB1B7-0DA3-4AAA-9075-E449D7B0851F

Q33708469-33242665-0A79-4B01-AD8C-C9C65DA46FD6

Q33708469-38B7291B-0E37-4ED2-927E-1638EC88A026

Q33708469-39549641-43D1-4399-B1F5-494517F9A716

Q33708469-39B7DFAB-C6DC-4BD5-B9E4-B673530314F5

Q33708469-663089CD-16F3-4807-977D-F85F15C33FD5

Q33708469-6DBDDAEF-70AC-4970-9375-CF1819B4C121

P304

Q33708469-95F710F0-76CE-4DEE-9FF2-1D8963D948C7

P31

Q33708469-24DD1192-972E-4E1D-8724-2F7A5795F87E

P356

Q33708469-BEBF42B3-86CD-4AFA-B8D1-0423B1A594F2

P433

Q33708469-98BA9B65-27BE-4513-8E74-44F9AFED4DD2

P478

Q33708469-8C2776F1-AF8D-4589-8CF9-60D19DF01C10

P50

Q33708469-7B7CD03D-0D24-4C90-92A5-A0AF09FD0EA8

Q33708469-B420D8F9-6103-4E8F-AFEA-03D03981DCE1

Q33708469-E772929D-E08A-4DE3-8829-4586CCC35799

P577

Q33708469-FF3DF269-E532-46E2-A31F-0745B0DBAF57

P5875

Q33708469-B6AD2CE1-96A1-4A2A-ABEA-D784D77C84EC

P698

Q33708469-61284518-76DB-4EE3-8AF2-0287E53EC149

P932

Q33708469-0FCD04D2-48B4-4AE4-BC9D-92955E178C18

P356

J.BBMT.2009.11.007

P1433

Biology of Blood and Marrow Transplantation

P1476

Race and outcomes of autologous hematopoietic cell transplantation for multiple myeloma.

@en

P2093

Angelo Maiolino

http://www.w3.org/2001/XMLSchema#string

Anna Hassebroek

http://www.w3.org/2001/XMLSchema#string

Asad Bashey

http://www.w3.org/2001/XMLSchema#string

Brendan Weiss

http://www.w3.org/2001/XMLSchema#string

Cesar O Freytes

http://www.w3.org/2001/XMLSchema#string

Charles F LeMaistre

http://www.w3.org/2001/XMLSchema#string

David Vesole

http://www.w3.org/2001/XMLSchema#string

Donna E Reece

http://www.w3.org/2001/XMLSchema#string

Fareeha Siddiqui

http://www.w3.org/2001/XMLSchema#string

Fausto Loberiza

http://www.w3.org/2001/XMLSchema#string

P2860

Myeloma and race: a review of the literature

Epidemiology of the plasma-cell disorders

Survival of blacks and whites after a cancer diagnosis.

High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma.

Prevalence of monoclonal gammopathy of undetermined significance among men in Ghana.

Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant.

A duplicated region is responsible for the poly(ADP-ribose) polymerase polymorphism, on chromosome 13, associated with a predisposition to cancer.

Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States

Improved survival in multiple myeloma and the impact of novel therapies.

Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders.

P304

395-402

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BBMT.2009.11.007

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Stephanie J Lee

Hillard M Lazarus

P577

2009-11-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38098545

http://www.w3.org/2001/XMLSchema#string

P698

19922808

http://www.w3.org/2001/XMLSchema#string

P932

2833344

http://www.w3.org/2001/XMLSchema#string